Australian Clinical Labs Ltd (ACL) — Strategic Asset Allocation Index
Australian Clinical Labs Ltd (ACL) has a Strategic Asset Allocation Index of 173.6% as of December 2025. Strategic assets (PP&E of AU$262.23 Million plus long-term investments of AU$-) total AU$262.23 Million, measured against net assets of AU$151.04 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ACL equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Australian Clinical Labs Ltd Strategic Asset Allocation Index (2016–2025)
This chart shows how Australian Clinical Labs Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2016 to 2025. As of December 2025, the index stands at 173.6%, representing strategic assets of AU$262.23 Million against net assets of AU$151.04 Million AUD. For live market cap and overall valuation, see Australian Clinical Labs Ltd market cap and net worth.
Annual Strategic Asset Allocation Index for Australian Clinical Labs Ltd (2016–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Australian Clinical Labs Ltd from 2016 to 2025, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See ACL net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (AUD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 157.1% | AU$270.11 Million | AU$270.11 Million | AU$- | AU$171.98 Million | ▲ +0.0 pp |
| 2024 | 157.1% | AU$270.11 Million | AU$270.11 Million | AU$- | AU$171.98 Million | ▼ -1.4 pp |
| 2024 | 158.5% | AU$281.70 Million | AU$281.70 Million | AU$- | AU$177.76 Million | ▲ +0.0 pp |
| 2023 | 158.5% | AU$281.70 Million | AU$281.70 Million | AU$- | AU$177.76 Million | ▼ -8.6 pp |
| 2023 | 167.0% | AU$288.44 Million | AU$288.44 Million | AU$- | AU$172.67 Million | ▲ +0.0 pp |
| 2022 | 167.0% | AU$288.44 Million | AU$288.44 Million | AU$- | AU$172.67 Million | ▲ +33.7 pp |
| 2021 | 133.4% | AU$310.20 Million | AU$310.20 Million | AU$- | AU$232.56 Million | ▼ -158.8 pp |
| 2020 | 292.2% | AU$239.34 Million | AU$238.34 Million | AU$1.00 Million | AU$81.91 Million | ▲ +10.9 pp |
| 2019 | 281.3% | AU$194.05 Million | AU$194.05 Million | AU$- | AU$68.99 Million | ▲ +128.8 pp |
| 2018 | 152.4% | AU$41.80 Million | AU$41.80 Million | AU$- | AU$27.42 Million | ▼ -464.4 pp |
| 2017 | 616.8% | AU$33.67 Million | AU$33.67 Million | AU$- | AU$5.46 Million | ▲ +348.6 pp |
| 2016 | 268.2% | AU$37.88 Million | AU$37.88 Million | AU$- | AU$14.12 Million | — |